An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.

Completed

Conditions studied: Stimulant Dependence

In brief

The purpose of this study is to determine whether performance on neurocognitive measures predicts treatment outcomes in individuals with substance abuse disorders. A second purpose is to compare the risk of damage, as well as actual damage, to DNA and other cell parts in people with substance abuse disorders to that of people who do not have substance abuse disorders.

Key facts

Study ID

NCT00628927

Run by

University of Cincinnati

People needed

217

Starts

2008-02-01

Expected to finish

2010-03-01

Last updated by the study team

2015-12-30

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Gateway Community Services — Jacksonville, Florida, United States
• Maryhaven — Columbus, Ohio, United States
• Willamette Family Treatment Services — Eugene, Oregon, United States
• ChangePoint, Inc. — Portland, Oregon, United States
• Nexus Recovery Center — Dallas, Texas, United States
• Recovery Centers of King County — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.